Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of acute myeloid leukemia (AML) with venetoclax failure

Treatment of acute myeloid leukemia (AML) with venetoclax failure

US Patent 11793802 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of LRRK2 kinase2025
Alvocidib prodrugs having increased bioavailability2025
CDK9 inhibitors2025
Inhibitors of NEK7 kinase2024
Inhibitors of LRRK2 kinase2024
Compositions comprising PKM2 modulators and methods of treatment using the same2023
Inhibitors of NEK7 kinase2023
Inhibitors of LRRK2 kinase2023
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof2022
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the2022
AXL kinase inhibitors and use of the same2022
Inhibitors of NEK7 kinase2021